Galantamine treatment of mice with established obesity (after 8 weeks on a high-fat diet) significantly lowers plasma IL-6, CCL2, leptin, and resistin levels, and reduces body weight, food intake, and abdominal white adipose depots (Satapathy et al., 2011). The gene discussed is LEP; the disease is obesity disorder.